Loading...
WAYMADE PLC — Citalopram Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #12 buyer for Citalopram · $2.6M import value · 64 shipments · UNITED KINGDOM · DGFT Verified
WAYMADE PLC is the #12 importer of Citalopram from India with $2.6M in import value and 64 verified shipments. WAYMADE PLC holds a 1.3% market share in Citalopram imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 55 formulations shipped to 1 country. Overall, WAYMADE PLC imports 2 pharmaceutical products worth $4.2M across 2 therapeutic categories.
Verified from 64 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GALPHA LABORATORIES LIMITED | $2.6M | 64 | 100.0% |
WAYMADE PLC sources Citalopram from 1 verified Indian supplier based on 64 customs records. The primary supplier is GALPHA LABORATORIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $3.5M | 71 | $50.0K |
| 11 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $3.5M | 75 | $47.0K |
| 12 | WAYMADE PLC ★ | UNITED KINGDOM | $3.2M | 64 | $50.0K |
| 13 | RISING PHARMA HOLDINGS, INC. | UNITED STATES | $3.1M | 174 | $18.0K |
| 10 | AUROLOGISTICS LLC | UNITED STATES | $3.0M | 60 | $50.0K |
WAYMADE PLC ranks #12 among 736 Citalopram importers from India. Average shipment value of $50.0K compared to the market average of $74.5K. The closest competitors by value are M/S. RANBAXY FARMACEUTICA LTDA : and MYLAN PHARMACEUTICALS INC,.
Destination countries from 64 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $2.6M | 64 | 100.0% |
WAYMADE PLC imports Citalopram to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $2.6M.
| Formulation | Value | Shipments |
|---|---|---|
| CITALOPRAM TABLETS 10MG,BATCH NOS.ET2300 | $150.0K | 3 |
| CITALOPRAM TABLETS 20MG,BATCH NOS.ET2301 | $100.0K | 2 |
| CITALOPRAM TABLETS 40MG,BATCH NOS.ET2302 | $100.0K | 2 |
| CITALOPRAM TABLETS 20MG BATCH NO.ET23204 TO ET23208 MFG.DT.JUL-2023 EXP.DT.JUN-2028 | $100.0K | 2 |
| CITALOPRAM TABLETS 20 MG BATCH NO.ET23320 TO 23324 MFG.DT.NOV-2023,EXP.DT.OCT-2028 (PACK-2 SX14 T)NOS | $83.6K | 3 |
| CITALOPRAM TABLETS 40MG,BATCH NOS.ET2301 | $58.0K | 2 |
| CITALOPRAM TABLETS 10MG,BATCH NOS.ET2301 | $57.8K | 2 |
| CITALOPRAM TABLETS 20MG,BATCH NO.ET22099 | $50.0K | 1 |
| CITALOPRAM TABLETS 20MG,BATCH NO.ET22104 |
What WAYMADE PLC and other importers must comply with to import Citalopram from India
Medicines and Healthcare products Regulatory Agency (MHRA)
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
UK GMP compliance; MHRA GMP inspection of manufacturing site
India exported $54.8M worth of Citalopram through 7,372 shipments from 257 suppliers to 101 countries, serving 736 buyers globally. WAYMADE PLC imports $2.6M of this total, accounting for 1.3% of India's Citalopram exports with 64 shipments from UNITED KINGDOM. This is verified from 64 customs shipment records covering 55 distinct formulations.
WAYMADE PLC's average Citalopram order value is $40.3K per consignment, based on 64 shipments totaling $2.6M. WAYMADE PLC is based in UNITED KINGDOM and ranks #12 among all Citalopram importers from India by value. The company sources from 1 verified supplier in India.
WAYMADE PLC sources Citalopram from 1 verified Indian supplier: GALPHA LABORATORIES LIMITED ($2.6M, 100.0%). This is based on 64 customs records.
WAYMADE PLC ranks #12 among 736 Citalopram importers from India with a 1.3% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($8.9M), TORRENT PHARMA INC ($7.3M), LEK S.A. ($4.1M). WAYMADE PLC processed 64 shipments from UNITED KINGDOM.
WAYMADE PLC imports 2 products worth $4.2M. Beyond Citalopram, top products include Hydrocortisone. View the complete WAYMADE PLC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Citalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for WAYMADE PLC's Citalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
WAYMADE PLC
Full Company Profile →
2 products · $4.2M total trade · 2 categories
| $50.0K |
| 1 |
| CITALOPRAM TABLETS 20MG,BATCH NO.ET22109 | $50.0K | 1 |
WAYMADE PLC imports 55 distinct Citalopram formulations from India. The top formulation is CITALOPRAM TABLETS 10MG,BATCH NOS.ET2300 with 3 shipments worth $150.0K.
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 736+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for WAYMADE PLC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Citalopram. For current order-level data, contact TransData Nexus.